Patrick Donnelly
Stock Analyst at Citigroup
(3.79)
# 720
Out of 5,090 analysts
351
Total ratings
53.72%
Success rate
7.05%
Average return
Main Sectors:
Stocks Rated by Patrick Donnelly
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| A Agilent Technologies | Maintains: Buy | $165 → $185 | $148.32 | +24.73% | 27 | Nov 25, 2025 | |
| MTD Mettler-Toledo International | Maintains: Buy | $1,600 → $1,700 | $1,422.81 | +19.48% | 15 | Nov 10, 2025 | |
| BIO Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $320.06 | +17.17% | 17 | Oct 30, 2025 | |
| BIO.B Bio-Rad Laboratories | Maintains: Buy | $350 → $375 | $319.10 | +17.52% | 17 | Oct 30, 2025 | |
| GH Guardant Health | Maintains: Buy | $65 → $100 | $108.75 | -8.04% | 10 | Oct 30, 2025 | |
| IQV IQVIA Holdings | Maintains: Neutral | $200 → $230 | $224.92 | +2.26% | 13 | Oct 29, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Neutral | $500 → $580 | $575.24 | +0.83% | 20 | Oct 23, 2025 | |
| QDEL QuidelOrtho | Downgrades: Neutral | $40 → $33 | $27.82 | +18.62% | 6 | Oct 7, 2025 | |
| ICLR ICON Public Limited Company | Downgrades: Neutral | $225 → $200 | $185.45 | +7.85% | 10 | Aug 21, 2025 | |
| TECH Bio-Techne | Upgrades: Buy | $55 → $70 | $63.37 | +10.46% | 12 | Aug 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $42 | $28.07 | +49.63% | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $40 → $38 | $48.22 | -21.19% | 17 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 → $200 | $184.04 | +8.67% | 21 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $60 → $80 | $74.86 | +6.87% | 15 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $85 → $80 | $127.80 | -37.40% | 17 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $18.11 | -17.17% | 12 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $22 → $18 | $11.15 | +61.43% | 8 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $185 | $184.18 | +0.45% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $265 | $227.13 | +16.67% | 12 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $23 | $14.48 | +58.89% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $20 | $16.50 | +21.25% | 3 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $75 | $101.15 | -25.85% | 13 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $28 | $22.92 | +22.16% | 4 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $135 → $145 | $102.55 | +41.39% | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $62 | $47.08 | +31.27% | 13 | Feb 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $265 → $300 | $396.37 | -24.31% | 24 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $2.58 | +249.51% | 6 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.75 → $2.75 | $3.02 | -8.94% | 4 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $250 → $260 | $261.48 | -0.57% | 11 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $6 | $10.37 | -42.14% | 4 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $28 → $32 | $7.31 | +338.06% | 2 | Nov 30, 2018 |
Agilent Technologies
Nov 25, 2025
Maintains: Buy
Price Target: $165 → $185
Current: $148.32
Upside: +24.73%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,600 → $1,700
Current: $1,422.81
Upside: +19.48%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $320.06
Upside: +17.17%
Bio-Rad Laboratories
Oct 30, 2025
Maintains: Buy
Price Target: $350 → $375
Current: $319.10
Upside: +17.52%
Guardant Health
Oct 30, 2025
Maintains: Buy
Price Target: $65 → $100
Current: $108.75
Upside: -8.04%
IQVIA Holdings
Oct 29, 2025
Maintains: Neutral
Price Target: $200 → $230
Current: $224.92
Upside: +2.26%
Thermo Fisher Scientific
Oct 23, 2025
Maintains: Neutral
Price Target: $500 → $580
Current: $575.24
Upside: +0.83%
QuidelOrtho
Oct 7, 2025
Downgrades: Neutral
Price Target: $40 → $33
Current: $27.82
Upside: +18.62%
ICON Public Limited Company
Aug 21, 2025
Downgrades: Neutral
Price Target: $225 → $200
Current: $185.45
Upside: +7.85%
Bio-Techne
Aug 21, 2025
Upgrades: Buy
Price Target: $55 → $70
Current: $63.37
Upside: +10.46%
Aug 13, 2025
Maintains: Buy
Price Target: $34 → $42
Current: $28.07
Upside: +49.63%
Aug 4, 2025
Maintains: Neutral
Price Target: $40 → $38
Current: $48.22
Upside: -21.19%
Jul 9, 2025
Upgrades: Buy
Price Target: $150 → $200
Current: $184.04
Upside: +8.67%
Jul 9, 2025
Upgrades: Buy
Price Target: $60 → $80
Current: $74.86
Upside: +6.87%
Jul 9, 2025
Downgrades: Sell
Price Target: $85 → $80
Current: $127.80
Upside: -37.40%
Mar 4, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $18.11
Upside: -17.17%
Mar 4, 2025
Maintains: Neutral
Price Target: $22 → $18
Current: $11.15
Upside: +61.43%
Mar 4, 2025
Downgrades: Neutral
Price Target: $185
Current: $184.18
Upside: +0.45%
Jan 30, 2025
Maintains: Buy
Price Target: $285 → $265
Current: $227.13
Upside: +16.67%
Dec 11, 2024
Downgrades: Neutral
Price Target: $30 → $23
Current: $14.48
Upside: +58.89%
Nov 6, 2024
Maintains: Buy
Price Target: $18 → $20
Current: $16.50
Upside: +21.25%
Nov 6, 2024
Maintains: Buy
Price Target: $80 → $75
Current: $101.15
Upside: -25.85%
Aug 7, 2024
Maintains: Buy
Price Target: $30 → $28
Current: $22.92
Upside: +22.16%
Jul 30, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $102.55
Upside: +41.39%
Feb 8, 2024
Maintains: Buy
Price Target: $64 → $62
Current: $47.08
Upside: +31.27%
Dec 11, 2023
Maintains: Neutral
Price Target: $265 → $300
Current: $396.37
Upside: -24.31%
Dec 11, 2023
Maintains: Buy
Price Target: $7 → $9
Current: $2.58
Upside: +249.51%
Aug 10, 2023
Maintains: Neutral
Price Target: $3.75 → $2.75
Current: $3.02
Upside: -8.94%
Feb 17, 2023
Maintains: Neutral
Price Target: $250 → $260
Current: $261.48
Upside: -0.57%
Nov 3, 2022
Maintains: Buy
Price Target: $8 → $6
Current: $10.37
Upside: -42.14%
Nov 30, 2018
Upgrades: Neutral
Price Target: $28 → $32
Current: $7.31
Upside: +338.06%